In the effort to diversify clinical trials, trust, access, and education play crucial roles

While funders and researchers have long held that clinical trials should enroll more diverse patients to better reflect the populations in which approved drugs will eventually be used, patient populations enrolled in clinical trials remain largely homogenous. (author introduction)

 #P4HEwebinarJuly2022